Kojar Pharma
LANGUAGE
English
繁體中文
About KOJAR
Introduction
History
Quality Policy
Facility Description
Process Capability
Analysis Capability
News
News
Products
ANTIPARASITIC PRODUCTSP ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
C ANTIVERTIGO PREPARATIONS
D ANTI-DEMENTIA DRUGS
ANXIOLYTICS, HYPNOTICS AND SEDATIVES
ANTIPSYCHOTICS
ANTI-PARKINSON DRUGS
ANALGESICS
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
ANTIGOUT PREPARATIONS
MUSCLE RELAXANTS
A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
ANTIVIRALS FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
Glucocorticoids
UROLOGICALS
OTHER GYNECOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
ANTISEPTICS AND DISINFECTANTS
CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
ANTIFUNGALS FOR DERMATOLOGICAL USE
LIPID MODIFYING AGENTS
ACE INHIBITORS
CALCIUM CHANNEL BLOCKERS
BETA BLOCKING AGENTS
PERIPHERAL VASODILATORS
ANTIHYPERTENSIVES
Sympathomimetics
THROAT PREPARATIONS
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
COUGH AND COLD PREPARATIONS
ANTIHISTAMINES FOR SYSTEMIC USE
DRUGS FOR ACID RELATED DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
BILE AND LIVER THERAPY
DRUGS FOR CONSTIPATION
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
ANTIOBESITY PREPARATIONS
DRUGS USED IN DIABETES
VITAMINS
OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
ANTITHROMBOTIC AGENTS
ANTIHEMORRHAGICS
ANTIANEMIC PREPARATIONS
OTHER HEMATOLOGICAL AGENTS
Contract M& D
Contract Manufacturing
Distribution and Agency
Join Us
Salary Policy
Bonus Insurance
Welfare benefits
Leave the system
Educational training
Work Environment
Current job openings
Contact Us
Contact Us
Route Description
Home
>
EMA publishes New Process Validation Guideline
2014-08-10
Back
